ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 348977 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 348977; 2) Community: the network communities that were significantly associated with the response to NSC 348977; 3) Molecule: the relationships between components within communities and NSC 348977; 4) MDR: the compounds that were significantly associated with the NSC 348977.

NSC Compound Enrichment Correlation
NSC 660313 Null 0.0396077140933374 0.11679556
NSC 693135 Null 0.0396077140933374 0.24316559
NSC 697730 Null 0.0396077140933374 0.098936016
NSC 700363 Liposomal Annamycin 0.0396077140933374 0.043930312
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0396077140933374 0.21168602
NSC 77038 WR 141 0.0396077140933374 0.44253716
NSC 135880 Null 0.0396077140933377 0.13880576
NSC 328410 Camptothecin Derivative 0.0396077140933377 0.0036852712
NSC 621727 Null 0.0396077140933379 0.48847015
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.0396077140933379 -0.21670134
Total:38  Current:31    [First] [Prev] [Next] [Last]